Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-25-263547
Filing Date
2025-11-04
Accepted
2025-11-04 07:14:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C d47111dsc14d9c.htm SC14D9C 7538
  Complete submission text file 0001193125-25-263547.txt   9209
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filed by) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87872 | Film No.: 251446435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)